csavar ne tedd hófehér ngal renal marker Letisztáz karom Lepontoz
Investigation of new biomarkers of kidney injury in renal transplant recipients undergoing graft biopsy - Michon - 2021 - Clinical Transplantation - Wiley Online Library
Which Marker Should We Use to Assess Acute Renal Injury - American College of Cardiology
NGAL - Bioporto
The Predictive Role of Biomarkers for the Detection of Acute Kidney Injury After Partial or Radical Nephrectomy: A Systematic Review of the Literature - European Urology Focus
NGAL - Acute kidney injury biomarker
NGAL Rapid Quantitative Test
Role of neutrophil gelatinase‑associated lipocalin in renal cell carcinoma (Review)
NGAL for the Detection of AKI: More Questions Than Answers - American College of Cardiology
The intensity and extent of the NGAL immunostaining increased... | Download Scientific Diagram
Urine/Plasma Neutrophil Gelatinase Associated Lipocalin Ratio Is a Sensitive and Specific Marker of Subclinical Acute Kidney Injury in Mice | PLOS ONE
Biomarkers of delayed graft function as a form of acute kidney injury in kidney transplantation | Scientific Reports
Neutrophil Gelatinase–Associated Lipocalin (NGAL) as a Marker of Kidney Damage - ScienceDirect
High dietary salt intake increases urinary NGAL excretion and creatinine clearance in healthy young adults | American Journal of Physiology-Renal Physiology
Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury | Biomarkers in Medicine
JCM | Free Full-Text | New Markers of Renal Failure in Multiple Myeloma and Monoclonal Gammopathies
ASSAY NOTES
Top: Anatomical locations for biomarkers indicative of an increased... | Download Scientific Diagram
Usefulness and limitations of neutrophil gelatinase-associated lipocalin in the assessment of kidney diseases | Semantic Scholar
Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury | Biomarkers in Medicine
NGAL - Bioporto
Frontiers | Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics
Frontiers | Advances in the study of subclinical AKI biomarkers